MEDIANA Co.Ltd
Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules. The company also exports ODM and own branded products th… Read more
MEDIANA Co.Ltd (041920) - Net Assets
Latest net assets as of September 2025: ₩132.36 Billion KRW
Based on the latest financial reports, MEDIANA Co.Ltd (041920) has net assets worth ₩132.36 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩147.44 Billion) and total liabilities (₩15.08 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩132.36 Billion |
| % of Total Assets | 89.77% |
| Annual Growth Rate | 16.69% |
| 5-Year Change | 87.08% |
| 10-Year Change | 266.12% |
| Growth Volatility | 7.25 |
MEDIANA Co.Ltd - Net Assets Trend (2014–2024)
This chart illustrates how MEDIANA Co.Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDIANA Co.Ltd (2014–2024)
The table below shows the annual net assets of MEDIANA Co.Ltd from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩127.80 Billion | +26.99% |
| 2023-12-31 | ₩100.64 Billion | +11.74% |
| 2022-12-31 | ₩90.06 Billion | +14.38% |
| 2021-12-31 | ₩78.74 Billion | +15.27% |
| 2020-12-31 | ₩68.31 Billion | +19.97% |
| 2019-12-31 | ₩56.94 Billion | +15.16% |
| 2018-12-31 | ₩49.44 Billion | +12.83% |
| 2017-12-31 | ₩43.82 Billion | +2.51% |
| 2016-12-31 | ₩42.75 Billion | +22.47% |
| 2015-12-31 | ₩34.91 Billion | +27.88% |
| 2014-12-31 | ₩27.30 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MEDIANA Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 640.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩91.48 Billion | 71.59% |
| Common Stock | ₩9.30 Billion | 7.28% |
| Other Components | ₩27.01 Billion | 21.14% |
| Total Equity | ₩127.80 Billion | 100.00% |
MEDIANA Co.Ltd Competitors by Market Cap
The table below lists competitors of MEDIANA Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SHEPHERD NEAME P. CONS.
F:43Y
|
$70.70 Million |
|
DCW Limited
NSE:DCW
|
$70.70 Million |
|
SAB Biotherapeutics Inc
NASDAQ:SABS
|
$70.73 Million |
|
Sound Financial Bancorp Inc
NASDAQ:SFBC
|
$70.75 Million |
|
Gwangjushinseg
KO:037710
|
$70.69 Million |
|
Grupo TMM SAB
PINK:GTMAY
|
$70.66 Million |
|
Xlife Sciences AG
SW:XLS
|
$70.64 Million |
|
VROYF
PINK:VROYF
|
$70.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDIANA Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 100,638,278,870 to 127,795,923,900, a change of 27,157,645,030 (27.0%).
- Net income of 6,212,040,500 contributed positively to equity growth.
- Dividend payments of 399,040,680 reduced retained earnings.
- Share repurchases of 16,287,355,790 reduced equity.
- New share issuances of 16,763,618,060 increased equity.
- Other factors increased equity by 20,868,382,940.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩6.21 Billion | +4.86% |
| Dividends Paid | ₩399.04 Million | -0.31% |
| Share Repurchases | ₩16.29 Billion | -12.74% |
| Share Issuances | ₩16.76 Billion | +13.12% |
| Other Changes | ₩20.87 Billion | +16.33% |
| Total Change | ₩- | 26.99% |
Book Value vs Market Value Analysis
This analysis compares MEDIANA Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.87x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.40x to 2.87x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩2688.54 | ₩19890.00 | x |
| 2017-12-31 | ₩2755.94 | ₩19890.00 | x |
| 2018-12-31 | ₩3109.44 | ₩19890.00 | x |
| 2019-12-31 | ₩3580.93 | ₩19890.00 | x |
| 2020-12-31 | ₩4291.61 | ₩19890.00 | x |
| 2021-12-31 | ₩4935.76 | ₩19890.00 | x |
| 2022-12-31 | ₩5643.67 | ₩19890.00 | x |
| 2023-12-31 | ₩5423.45 | ₩19890.00 | x |
| 2024-12-31 | ₩6922.23 | ₩19890.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDIANA Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.89%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.09x
- Recent ROE (4.86%) is below the historical average (11.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 13.30% | 9.46% | 1.04x | 1.36x | ₩899.68 Million |
| 2015 | 20.29% | 15.16% | 1.05x | 1.27x | ₩3.59 Billion |
| 2016 | 18.61% | 14.90% | 0.98x | 1.27x | ₩3.68 Billion |
| 2017 | 7.18% | 6.03% | 0.99x | 1.21x | ₩-1.23 Billion |
| 2018 | 6.55% | 6.92% | 0.82x | 1.15x | ₩-1.70 Billion |
| 2019 | 11.85% | 13.94% | 0.75x | 1.14x | ₩1.05 Billion |
| 2020 | 16.46% | 16.65% | 0.88x | 1.12x | ₩4.41 Billion |
| 2021 | 11.14% | 15.45% | 0.63x | 1.15x | ₩900.56 Million |
| 2022 | 11.77% | 15.51% | 0.66x | 1.15x | ₩1.59 Billion |
| 2023 | 8.84% | 11.34% | 0.70x | 1.11x | ₩-1.17 Billion |
| 2024 | 4.86% | 10.89% | 0.41x | 1.09x | ₩-6.57 Billion |
Industry Comparison
This section compares MEDIANA Co.Ltd's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $98,200,243,269
- Average return on equity (ROE) among peers: -9.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDIANA Co.Ltd (041920) | ₩132.36 Billion | 13.30% | 0.11x | $70.69 Million |
| InBody Co.Ltd (041830) | $183.73 Billion | 18.52% | 0.11x | $209.22 Million |
| Value Added Technology Co. Ltd (043150) | $349.29 Billion | 22.01% | 0.46x | $111.16 Million |
| MEKICS Co Ltd (058110) | $7.87 Billion | -24.74% | 1.89x | $14.68 Million |
| Meta Biomed Co. Ltd (059210) | $39.05 Billion | 3.02% | 0.38x | $51.83 Million |
| INFINITT Healthcare Co. Ltd (071200) | $77.28 Billion | 6.38% | 0.20x | $53.10 Million |
| i-SENS Inc (099190) | $118.81 Billion | 12.18% | 0.38x | $125.86 Million |
| Sewoon Medical Co. Ltd (100700) | $46.71 Billion | 7.88% | 0.18x | $33.93 Million |
| CU Medical Systems Inc (115480) | $58.36 Billion | 16.15% | 0.51x | $14.13 Million |
| PeopleBio Inc (304840) | $2.70 Billion | -148.07% | 0.61x | $5.53 Million |